Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

YOU WONT BELIEVE: Purdue pharma - What They Never Told You

OxyContin maker Purdue Pharma's settlement, by the numbers

OxyContin maker Purdue Pharma's deal to resolve thousands of lawsuits over the toll of opioids is taking effect Friday and the company is being replaced by a new entity

The Independent UK

Purdue Pharma Faces $5.5B Criminal Sentence for Deceiving Regulators and Boosting Opioid Sales

Purdue Pharma has been sentenced to pay $5.5 billion after pleading guilty to deceiving regulators and fueling the US opioid crisis through aggressive and illegal opioid sales practices.

International Business Times

US opioid crisis: families speak out after Purdue Pharma sentencing

Relatives of opioid overdose victims reacted outside a US court after Purdue Pharma was sentenced over its role in the opioid crisis.

Euronews

From analysis to the latest developments in health,
read the most diverse news in one place.

OxyContin maker Purdue Pharma's criminal sentence could be the last step before company dissolves

OxyContin maker Purdue Pharma is expected to be ordered to pay $225 million in a criminal case related to how it sold its blockbuster opioid painkiller

The Independent UK

OxyContin Maker Purdue Pharma Expected To Finally Be Sentenced In Opioid Crisis Case

Years after pleading guilty for conduct that helped create the opioid crisis, Purdue Pharma's settlement with the federal government appears to be moving forward.

International Business Times

Purdue Pharma to be sentenced in criminal opioids case, allowing settlement money to flow

A judge is expected to sentence OxyContin maker Purdue Pharma to forfeit $225 million to the U.S. government

The Independent UK

Two charities that received £1.1m from Sackler Trust kept anonymous to prevent ‘serious prejudice’

British charitable trust that draws on OxyContin-maker fortune says it exempted names to protect reputations

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Judge to explain why he's approving Purdue Pharma settlement plan, which calls for $7B from Sacklers

A judge is set to explain why he's approving a plan for OxyContin maker Purdue Pharma to settle thousands of lawsuits over the toll of opioids

The Independent UK

Purdue Pharma's deal means money for some victims, end of Purdue company name. Here's what to know

OxyContin maker Purdue Pharma's efforts to settle thousands of lawsuits over the toll of opioids is on the verge of approval

The Independent UK

Deal Dispatch: Warner Bros., Bill.com, C3 AI—Key Auctions And Buyouts Shake The Market

Purdue Pharma won court approval to exit bankruptcy, ending six years of litigation over its multibillion-dollar opioid settlement and the Sackler family’s liability releases. Purdue's Chapter 11 plan provides an estimated $7.4 billion to address nationwide opioid harm.

Benzinga

Latest opioid settlement plan with OxyContin maker Purdue and Sackler family getting few objections

The company that makes OxyContin, members of the Sackler family who own it and many groups that sued over its role in the opioid crisis are asking a judge to approve a settlement plan

The Independent UK

Purdue Pharma plan moves forward despite challenge from opioid victim

Plaintiff says company’s bid to exit bankruptcy omits US government plan to seize $225m that should go to victims

The Guardian - US

Purdue Pharma's $7B opioid settlement plan could get votes from victims and cities

A judge could decide Friday whether to advance OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids

The Independent UK

A judge could advance Purdue Pharma's $7B opioid settlement after all 50 states back it

A judge is being asked to clear the way for local governments and individual victims to vote on OxyContin maker Purdue Pharma’s plan to settle thousands of lawsuits over the toll of opioids

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Purdue Pharma to pay $7.4 billion in opioid lawsuit settlement

Besides the hefty financial reward, the settlement also ends the Sackler family’s ownership of Purdue Pharma and their ability to sell opioids in the U.S.

Al Jazeera

Purdue Pharma $7.4bn opioid settlement wins broad support from US states

The suit, brought by 55 attorneys general, will help compensate victims and fund addiction treatment programmes.

The Independent UK

Sackler family to pay $6.5 billion for their role in ‘fueling’ opioid epidemic which has killed hundreds of thousands

Sackler family, who owned pharmaceutical company Purdue Pharma, will no longer be in control of the company or permitted to sell opioids if the new settlement plan is approved

Latin Times

New York AG Blasts Sackler Family While Announcing $7.4 Billion Purdue Pharma Settlement: 'No Amount of Money Will Ever Fully Repair The Damage They Caused'

New York's AG shared news of The Sackler family and Purdue Pharma settlement, while stating "no amount of money" could reverse the destruction caused.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Purdue Pharma and owners to pay $7.4 billion in settlement to lawsuits over the toll of OxyContin

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to settle lawsuits over the toll of the powerful prescription painkiller

International Business Times

Sacklers, Purdue To Pay $7.4 Bn Over Opioid Crisis

Several US states have reached a $7.4 billion settlement with the Sackler family and their pharmaceutical company Purdue over the opioid crisis that has ravaged the lives of millions of Americans, officials said Thursday.

The Guardian - US

Purdue Pharma and Sacklers reach new $7.4bn settlement over opioids crisis

Settlement resolves thousands of lawsuits alleging Oxycontin caused addiction crisis

The Guardian - US

Ex-McKinsey partner pleads guilty to destroying records on opioids

Martin Elling pleads guilty to destroying records on advice provided to Purdue Pharma on how to ‘turbocharge’ sales

International Business Times

McKinsey To Pay $650 Mn To Settle US Criminal Case On Opioids

Consulting giant McKinsey & Company will pay $650 million to settle US criminal charges that it collaborated with Purdue Pharma to intentionally misbrand opioids, worsening a public health crisis, officials announced Friday.

The Guardian - US

McKinsey to pay $650m to resolve US investigation into opioid crisis role

Consultancy giant agrees to two criminal counts, including for conspiring with drug manufacturers, in DoJ settlement